News

Biohaven rises as FDA cancels AdCom on lead drug

Biohaven (NYSE:BHVN) shares spiked in the premarket on Friday after the FDA revoked an advisory committee meeting scheduled ...

Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year

Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...